XML 59 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Shareholders' Equity (Details)
 1 Months Ended 12 Months Ended
Oct. 26, 2020
Aug. 31, 2020
USD ($)
$ / shares
shares
Jan. 31, 2020
$ / shares
shares
Jun. 17, 2019
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
Dec. 31, 2018
USD ($)
$ / shares
Sep. 03, 2019
₪ / shares
shares
Shareholders' Equity (Details) [Line Items]                
Aggregate amount (in Dollars) | $           $ 312,500 $ 3,684,000  
Purchase price (in Dollars per share) | $ / shares     $ 12.00 $ 20.87 $ 16.00 $ 2,210 $ 2.21  
Ordinary shares     1,109,245 2,262,443 4,624,500      
Aggregate purchase price (in Dollars) | $       $ 5,000,000   $ 5,000,000    
Aggregate purchase price (in Dollars) | $         $ 74,000,000      
Net proceeds (in Dollars) | $         71,000,000      
Net proceeds from IPO (in Dollars) | $         $ 169,348,000  
Percentage of discount price     25.00%          
Ordinary shares reserved under the ESOP               8,041,936
Price per share (in New Shekels per share) | ₪ / shares               ₪ 0.01
Number of exercised shares         1,027,151      
Description of share-based compensation expenses the Company entered into an amendment to a business development agreement (“the Agreement”) dated February 4, 2020 with two service providers pursuant to which the Company paid an aggregate one-time payment of $400 thousand plus VAT and issued to them warrants to purchase an aggregate of 650,000 ordinary shares at an exercise price of $18 per share with a graded vesting ending 10 weeks following the grant date (subject to a standard cashless exercise provision). As a result, the Company recorded an expense of $6.1 million for the warrants granted. The service providers waived any and all past, present and future compensation to which they are or may be entitled pursuant to the Agreement and all activities undertaking on behalf of the Company, including the right to a percentage from future revenues from any of the Company’s systems and the issuance of warrants.              
Nanox PLC [Member]                
Shareholders' Equity (Details) [Line Items]                
Aggregate amount (in Dollars) | $           $ 4,038,000    
IPO [Member]                
Shareholders' Equity (Details) [Line Items]                
Purchase price (in Dollars per share) | $ / shares   $ 18            
Ordinary shares   9,178,744            
Aggregate purchase price (in Dollars) | $   $ 190,000,000            
Stock Issued During Period, Shares, New Issues   9,178,744            
Over-Allotment Option [Member]                
Shareholders' Equity (Details) [Line Items]                
Stock Issued During Period, Shares, New Issues   1,376,812            
Equity Incentive Plan [Member]                
Shareholders' Equity (Details) [Line Items]                
Ordinary shares         2,978,247      
Warrants [Member]                
Shareholders' Equity (Details) [Line Items]                
Ordinary shares       2,262,443        
Employees, Officers and Directors [Member]                
Shareholders' Equity (Details) [Line Items]                
Ordinary shares         730,734      
Exercise price per share (in Dollars per share) | $ / shares         $ 13.53